Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.69 |
| ▸ | MAPT | P10636 | 8/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.69 |
| ▸ | RXRA | P19793 | 5/20 | 0.69 |
| ▸ | RARA | P10276 | 4/20 | 0.69 |
| ▸ | RARB | P10826 | 4/20 | 0.69 |
| ▸ | RARG | P13631 | 4/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.69 |
| ▸ | APP | P05067 | 4/20 | 0.69 |
| ▸ | SNCA | P37840 | 4/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.69 |
| ▸ | BLM | P54132 | 3/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | RXRB | P28702 | 2/20 | 0.69 |
| ▸ | RXRG | P48443 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL58183 | 0.92 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL4860926 | 0.92 | ALDH1A1 (0.72) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL3427341 | 0.91 | ALDH1A1 (0.71) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL11407893 | 0.91 | ALDH1A1 (0.71) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL1362317 | 0.90 | ALDH1A1 (0.80) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL19668732 | 0.90 | ALDH1A1 (0.69) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL2508378 | 0.90 | ALDH1A1 (0.69) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL2012981 | 0.89 | ALDH1A1 (0.68) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL2005202 | 0.89 | ALDH1A1 (0.68) | ALDH1A1MAPTCYP3A4RXRARARA | |
| Alcohol SCHEMBL1362664 | 0.89 | ALDH1A1 (0.73) | ALDH1A1MAPTCYP3A4RXRARARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100144867-A1 | USE OF LECITHIN:RETINOL ACYL TRANSFERASE GENE PROMOTER METHYLATION IN EVALUATING THE CANCER STATE OF SUBJECT | CORNELL RESEARCH FOUNDATION, INC. (US) | 2010-06-10 | — | — | US | claimed |
| EP-2099931-A2 | USE OF LECITHIN:RETINOL ACYL TRANSFERASE GENE PROMOTER METHYLATION IN EVALUATING THE CANCER STATE OF A SUBJECT | CORNELL RESEARCH FOUNDATION, INC. (US) | 2009-09-16 | — | — | EP | claimed |
| WO-2008077095-A2 | USE OF LECITHIN:RETINOL ACYL TRANSFERASE GENE PROMOTER METHYLATION IN EVALUATING THE CANCER STATE OF A SUBJECT | CORNELL RESEARCH FOUNDATION, INC. (US) | 2008-06-26 | — | — | WO | claimed |
| EP-2598471-B1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEM CO (US) | 2020-11-25 | — | — | EP | disclosed |
| US-9532938-B2 | Esters of O-substituted hydroxy carboxylic acids and preparations thereof | EASTMAN CHEMICAL COMPANY (US) | 2017-01-03 | — | — | US | disclosed |
| US-20150025247-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEM CO (US) | 2015-01-22 | — | — | US | disclosed |
| US-8846723-B2 | Esters of O-substituted hydroxy carboxylic acids and preparations thereof | EASTMAN CHEMICAL COMPANY (US) | 2014-09-30 | — | — | US | disclosed |
| EP-2598471-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | Eastman Chemical Company (US) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012015790-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2012-02-02 | — | — | WO | disclosed |
| US-20120029198-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2012-02-02 | — | — | US | disclosed |
| EP-2349148-A1 | SYSTEM AND METHOD FOR TREATMENT OF LENS RELATED DISORDERS | Glostrup Hospital (DK) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010015255-A1 | SYSTEM AND METHOD FOR TREATMENT OF LENS RELATED DISORDERS | GLOSTRUP HOSPITAL (DK) | 2010-02-11 | — | — | WO | disclosed |
| US-20090227649-A1 | Management of Ophthalmologic Disorders, Including Macular Degeneration | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-09-10 | — | — | US | disclosed |
| EP-1727529-A2 | PREVENTION OF RETINOPATHY BY INHIBITION OF THE VISUAL CYCLE | Larsen, Lars, Michael (DK) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005087210-A2 | PREVENTION OF RETINOPATHY BY INHIBITION OF THE VISUAL CYCLE | LARSEN LARS MICHAEL (DK) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025247-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | HCAR2, OXER1, FASN | ALDH1A1 254/4885MAPT 4849/4885CYP3A4 227/4885 |
| US-20090227649-A1 | Management of Ophthalmologic Disorders, Including Macular Degeneration | ALDH1A2, PDE6C, PDE6A | ALDH1A1 963/4885MAPT 2307/4885CYP3A4 4527/4885 |
| US-20120029198-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | HCAR2, OXER1, FASN | ALDH1A1 254/4885MAPT 4849/4885CYP3A4 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.